๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Beta Thalassemia Major Anemia

Atrial Fibrillation in Beta-Thalassemia NCT05508932n/a1 site๐Ÿ“ Ferrara University Hospital of Ferrara Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (ฮฒ)-Thalassemia NCT04143724Phase 226 sites๐Ÿ“ Los Angeles๐Ÿ“ New York๐Ÿ“ Guangzhou Celgene ยท Tests: ACE-536 Clinical Study of Super Transplantation in the Treatment of Severe ฮฒ-thalassemia NCT06734520NA2 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou Guangzhou Women and Children's Medical Center ยท Tests: super-transplantation in 3 severe ฮฒ -thalassemia pediatric patients. Long-term Follow-up Study of BHC001 for TDT NCT06314529n/a2 sites๐Ÿ“ Nanning๐Ÿ“ Changsha Bioray Laboratories ยท Tests: Assessments A Study of Immune Suppression Treatment for People With Sickle Cell Disease or ฮฒ-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT) NCT05736419Phase 26 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Fludarabine, Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil, Rabbit ATG Study of the Role of Genetic Modifiers in Hemoglobinopathies NCT05799118n/a26 sites๐Ÿ“ Boston๐Ÿ“ Luanda๐Ÿ“ Buenos Aires Cyprus Institute of Neurology and Genetics ยท Tests: GWAS A Trial Testing SP-420 in Subjects With Transfusion-dependent ฮฒ-thalassemia or Low-risk Myelodysplastic Syndromes NCT05693909Phase 21 site๐Ÿ“ Copenhagen Pharmacosmos A/S ยท Tests: SP-420 Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC NCT04528355n/a1 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: data collection MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies NCT05735717Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Fludarabine, Busulfan, Melphalan, Rituximab, Levetiracetam A Long-term Follow-up Study in Participants Who Received CS-101 NCT06479616NA1 site๐Ÿ“ Shanghai Children's Hospital of Fudan University ยท Tests: CS-101 T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338Phase 1, Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: CD3/CD19 depleted leukocytes, CD45RA depleted leukocytes, Hydroxyurea, Rituximab, Alemtuzumab Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia Major NCT07112703NA1 site๐Ÿ“ Zagazig Rawan Mohammed Khairy Mostafa Elsawy ยท Tests: Incentive spirometer exercises, Diaphragmatic breathing, Pursed lip breathing:, Costal breathing exercises A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or ฮฒ-thalassemia NCT06073860n/a2 sites๐Ÿ“ Seoul๐Ÿ“ Seoul Bristol-Myers Squibb ยท Tests: Luspatercept A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent ฮฒ-Thalassemia [TDT] NCT05762510EARLY Phase 11 site๐Ÿ“ Nanning First Affiliated Hospital of Guangxi Medical University ยท Tests: GMCN-508B (LentiRed) Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia NCT06490627Phase 21 site๐Ÿ“ Karachi National Institute of Blood and Marrow Transplant (NIBMT), โ€ฆ ยท Tests: Thalidomide, Thalidomide Transfusion-Related Changes in Oxidative Stress Biomarkers in Neonates NCT07672275n/a1 site๐Ÿ“ Graz Medical University of Graz ยท Tests: Peroxide analysis-TOC Omnignostica Forschungs GmbH, Near Infrared Imaging Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease NCT02675959Phase 24 sites๐Ÿ“ Los Angeles๐Ÿ“ Gainesville๐Ÿ“ Valhalla New York Medical College ยท Tests: Defibrotide Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent ฮฒ-Thalassemia and Severe Sickle Cell Disease NCT05477563Phase 36 sites๐Ÿ“ New York๐Ÿ“ Charlotte๐Ÿ“ Nashville Vertex Pharmaceuticals Incorporated ยท Tests: CTX001 Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients NCT06219239NA1 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: KL003 cell injection Drug Product Safety and Efficacy of Hemoglobin F Inducers in Patients With Beta Thalassemia NCT07673302NA1 site๐Ÿ“ Rawalpindi Riphah International University ยท Tests: Thalidomide, Hydroxy Urea A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent ฮฒ-thalassemia NCT06772766Phase 12 sites๐Ÿ“ Nanning๐Ÿ“ Haikou Mabwell (Shanghai) Bioscience Co., Ltd. ยท Tests: 9MW3011, 9MW3011 placebo ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia NCT06364774Phase 1, Phase 21 site๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: ALS20 A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials NCT04064060Phase 3143 sites๐Ÿ“ Los Angeles๐Ÿ“ Oakland๐Ÿ“ Stanford Celgene ยท Tests: Luspatercept Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent ฮฒ-Thalassemia NCT07884773Phase 31 site๐Ÿ“ Peshawar Khyber Medical University Peshawar ยท Tests: Thalidomide, Danazol, Prednisolone International Registry of Patients With Alpha Thalassemia NCT04872179n/a1 site๐Ÿ“ San Francisco University of California, San Francisco A Study of Participants with ฮ’-Thalassemia Treated with Betibeglogene Autotemcel NCT06271512n/a6 sites๐Ÿ“ Oakland๐Ÿ“ Palo Alto๐Ÿ“ Minneapolis Genetix Biotherapeutics Inc. ยท Tests: No Intervention Long-term Follow-up Study of BRL-101 for TDT NCT06298630n/a7 sites๐Ÿ“ Guangzhou๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Bioray Laboratories ยท Tests: Assessments Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease NCT01245179Phase 11 site๐Ÿ“ Augusta Abdullah Kutlar ยท Tests: panobinostat RADeep Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) NCT06213402n/a1 site๐Ÿ“ Barcelona Hospital Universitari Vall d'Hebron Research Institute ยท Tests: Data collection from EHR. Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT NCT01962415Phase 21 site๐Ÿ“ Pittsburgh Paul Szabolcs ยท Tests: Hydroxyurea, Alemtuzumab, Fludarabine, Melphalan, Thiotepa
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy